Physician profile
John N Hoffman
NPI 1689643173
$678.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $103 · 2021: $91.29 · 2022: $132 · 2023: $174 · 2024: $17.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.93 | 2019-2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $72.42 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $66.28 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $42.88 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.38 | 2022 | |
| Amarin Pharma, INC. | $38.81 | 2020-2022 | |
| Amgen INC. | $35.30 | 2020-2021 | |
| Genzyme Corporation | $27.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.35 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.99 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $24.68 | 2022 | |
| Jazz Pharmaceuticals INC. | $23.20 | 2023 | |
| Gilead Sciences, INC. | $21.36 | 2021 | |
| United Therapeutics Corporation | $20.12 | 2023 | Tyvaso |
| Boston Scientific Corporation | $17.78 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.28 | 2023 | |
| Hologic INC | $17.21 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.16 | 2023 | Dupixent |
| Mylan Specialty L.P. | $15.54 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.